找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology; Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe

[復(fù)制鏈接]
樓主: 軍械
11#
發(fā)表于 2025-3-23 10:35:03 | 只看該作者
Conventional Radiological and PET-CT Assessment of Treatment Response Evaluation in Chemotherapy Set as surrogate markers to determine the disease status and to strategically plan therapeutic management. The chapter includes the advantages and limitations of conventional imaging and PET/CT techniques in the assessment of treatment response to chemotherapy in various cancer types, including the criteria used and recommendations.
12#
發(fā)表于 2025-3-23 16:03:02 | 只看該作者
13#
發(fā)表于 2025-3-23 19:45:56 | 只看該作者
14#
發(fā)表于 2025-3-24 01:43:29 | 只看該作者
Gabriele Hooffacker,Robert Kohlick approaches appear in most recent guidelines as part of the recommendations on the appropriate use of optimal imaging in solid tumors and lymphoma. This chapter will provide a general overview of various criteria used to assess tumor response to therapy and their advantages, limitations, controversies, and challenges.
15#
發(fā)表于 2025-3-24 06:03:07 | 只看該作者
Game Theory and Multi-Agent Optimization,onventional imaging and PET/CT in the postsurgical setting of various cancer types, reviewing several guidelines and recommendations. Besides, the potential pitfalls in the image interpretation will be discussed.
16#
發(fā)表于 2025-3-24 07:58:42 | 只看該作者
17#
發(fā)表于 2025-3-24 14:20:51 | 只看該作者
18#
發(fā)表于 2025-3-24 18:09:32 | 只看該作者
19#
發(fā)表于 2025-3-24 22:39:25 | 只看該作者
Gabriele Hooffacker,Robert Kohlickware and sequence design, a vast number of functional MRI parameters are available, which are at different stages of validation. Standardisation and validation remain a challenge to implementation. The chapter will cover the advantages, limitations and pitfalls of using MRI for treatment response assessment in oncology patients.
20#
發(fā)表于 2025-3-24 23:13:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
铜鼓县| 长泰县| 桐柏县| 禄丰县| 宁波市| 乌拉特前旗| 汝南县| 肇东市| 哈巴河县| 竹溪县| 东港市| 长顺县| 新建县| 湟源县| 浠水县| 皮山县| 武冈市| 花莲市| 衡东县| 陇西县| 寿宁县| 清丰县| 沙湾县| 扎赉特旗| 东兰县| 关岭| 木兰县| 洪雅县| 峨山| 车险| 四子王旗| 长岛县| 苍溪县| 峨边| 丽江市| 贺兰县| 丰台区| 彩票| 威远县| 陕西省| 巩留县|